(b).
| Parameters | UDCA (n = 30) | Placebo (n = 30) | ||||
|---|---|---|---|---|---|---|
| Baseline (F0) | 8 weeks (F1) | 8 weeks—baseline (Δ) | Baseline (F0) | 8 weeks (F1) | 8 weeks—baseline (Δ) | |
| Anthropometry and BP | ||||||
| BMI (kg/m2) | 32.4 ± 5.9 | 31.9 ± 5.7 | −0.5 ± 0.7† | 31.2 ± 5.3 | 31.1 ± 5.4 | −0.2 ± 0.5∗ |
| WC (cm) | 106.7 ± 11.2 | 102 ± 11 | −4.7 ± 4.5† | 101 ± 13.3 | 98.5 ± 11.7 | −2.5 ± 4.4† |
| BP systolic (mmHg) | 134.8 ± 17.4 | 131.7 ± 14.2 | −3.2 ± 14.6 | 130 ± 16.1 | 128.7 ± 19.3 | −1.3 ± 16.2 |
| BP diastolic (mmHg) | 83.8 ± 7.4 | 82.3 ± 6.9 | −1.5 ± 4.9 | 82.2 ± 8.1 | 84.2 ± 8.6 | 2 ± 7.3∗ |
All values are expressed as mean ± SD. ∗p < 0.05: Independent sample t-test compared with UDCA group. †p < 0.05: Wilcoxon's signed ranks test compared 8 weeks and baseline in the UDCA group or compared 8 weeks and baseline in the placebo group. F0: beginning of study; F1: end of study; WC: waist circumference; BP: blood pressure.